Expression of miR‑21 and miR‑138 in colon cancer and its effect on cell proliferation and prognosis
Changxuan You(Southern Medical University), Xuewu Huang(First Affiliated Hospital of Guangzhou University of Chinese Medicine), Liming Jin(Zhejiang Provincial People's Hospital), Xuelong Jiao(Qingdao University), Bo Shen(Nanjing Medical University), Qi Xu(Zhejiang Cancer Hospital)
Cited by 41
Related Papers
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
|The Lancet Oncology|2011|4.1k
Final overall survival results from a randomised, phase III study of erlotinib versus chemotherapy as first-line treatment of EGFR mutation-positive advanced non-small-cell lung cancer (OPTIMAL, CTONG-0802)
|Annals of Oncology|2015|467
TRPM7 regulates the migration of human nasopharyngeal carcinoma cell by mediating Ca2+ influx
|Cell Calcium|2010|135
CCNB2 overexpression is a poor prognostic biomarker in Chinese NSCLC patients
|Biomedicine & Pharmacotherapy|2015|126